New startup ideas · Health and bio · Healthcare and bio
startup idea
Vitalane
A global marketplace for measuring your own biology, ranked by what actually changes with age.
Vitalane is a consumer app that sells at-home biology panels (blood, saliva, stool, wearable-derived) from independent labs and then sells the follow-on interventions - supplements, sleep and training protocols, coached programs - from vetted vendors in the same checkout.
- Marketplace
- Consumer
- $100B+ market
- Creates a new category
- Global from day one
3/5
venture judge
7
similar startups, last 2 years (62 all-time)
82%
of 4 nearest real companies still alive
yes
8 matching federal grants and programs
Direction supported by government programs and grants
Test it before you build it
$800 · 4 weeks · 40 prospects
For $800 and 4 weeks, prove that self-pay panel buyers will pay again for a ranked follow-on intervention - the second transaction the whole marketplace runs on.
Riskiest assumption · People aged 45-60 who already buy self-pay panels will pay a second time - for the next panel and for a ranked intervention tied to their results - rather than churning after two tests because nothing they measured changed how they feel.
1Focus group: who and where
Adults 45-60 who paid out of pocket for at least two blood panels in the past year (Function Health, InsideTracker, Marek Health or Quest consumer-initiated tests) and just received results they do not know how to act on.
where to find 40 · r/Biohackers and r/PeterAttia on Reddit, where buyers post their panel results and ask what to do next (community); local biohacker and longevity Meetup groups in Austin and New York, the two launch metros (event); and the review threads for Function Health and InsideTracker on Trustpilot and Reddit, where repeat self-pay buyers complain that results never change anything (channel).
2Sell first, build later
A concierge results-to-protocol report sold today for $75 (send your panel PDF, get the 3 interventions that moved your flagged markers for similar profiles, with vetted vendor links, in 5 days), and a $199 per quarter founding subscription reserved now, first kits shipping the week of November 2, 2026.
the ask · $75 per concierge report now; $199 per quarter for the subscription, reserved with a $49 deposit
a real yes · Money moved counts: a charged $75 report or a $49 reservation on a card. Upvotes, 'I would totally use this' comments and requests for a free version do not count.
3Small experiments
The first one attacks the riskiest assumption; each ends with a number that says whether to run the next.
1. Sell the follow-on protocol
$150 · 14 days
DM 20 people who posted fresh panel results in r/Biohackers or r/PeterAttia and sell a $75 concierge report: they send the panel PDF, the founder manually maps flagged markers to 3 vendor interventions with published evidence and buy links, delivered in 5 days. Track who pays and who then buys a recommended product through the links within 14 days. This is the second transaction, done by hand before any app exists.
keep going if · 8 of 20 pay $75, and 5 of those 8 buy a recommended product within 14 days
2. Vendor listing LOIs
$0 · 10 days
Call 12 supplement, sleep-coaching and training-program vendors that already sell to this cohort and ask them to sign a one-page listing LOI: 20% take rate, outcome reporting required, first cohort in Austin and New York. The founder runs every call from a two-page marketplace memo, no deck.
keep going if · 6 of 12 vendors sign the listing LOI
3. Repeat-panel churn interviews
$200 · 10 days
Run 20 paid 20-minute calls ($10 gift card each) with people who bought 2+ panels, recruited from the same subreddits and Meetup groups. Ask what they did after each result, whether they bought anything because of it, and why they stopped or continued testing.
keep going if · 12 of 20 bought or seriously tried to buy an intervention because of a panel result in the past 6 months
4. Priced reservation page
$450 · 14 days
Put up a one-page site with the $199 per quarter offer (panel, ranked next test, vendor rankings) and a $49 refundable reservation checkout for the Austin and New York founding cohort. Send the 40 prospects to it and back it with $300 of Reddit ads in r/Biohackers.
keep going if · 12 reservations of $49, at least 8 from the 40 named prospects
4Collect a deposit up front
Tesla took $1,000 refundable reservations for the Model 3 and $100 for the Cybertruck before building either: the deposit is the measurement, not the revenue.
$49
per prospect, refundable
how · A $49 refundable reservation taken at checkout on the landing page - a consumer-sized pre-order with a named ship week, because this buyer already pays for panels by card online and a card charge is the only honest signal at this price point. set up: Stripe Checkout ↗
what it reserves · One of 100 founding slots in Austin or New York, the $199 per quarter price locked for the first year, and the first kit shipping the week of November 2, 2026; the $49 is credited to the first quarter.
refund · Fully refundable in one click any time before the first kit ships.
target · 12 reservations from 40 prospects within 30 days
before taking money · All panels must run through CLIA-certified partner labs, the offer must make no diagnostic or treatment claims, and counsel should review the FTC substantiation for any statement that a product 'moved' a marker before it appears in a ranking.
Go: build it if
12+ $49 reservations from 40 prospects, 8 of 20 pay $75 for the concierge protocol with at least 5 buying a recommended product within 14 days, and 6 of 12 vendors sign listing LOIs.
Kill: stop if
Fewer than 5 reservations from 40 prospects, fewer than 3 of 20 pay for the concierge protocol, or fewer than 2 concierge buyers make any follow-on purchase within 14 days - the second transaction the model depends on is not there.
5 Scripts to run itoutreach message, landing copy, deposit terms · click to open
outreach message
Saw your post about your latest bloodwork - you paid for the panel and you are still guessing what to actually do with the numbers. I am building Vitalane. For $75 I will personally map your results to the 3 interventions that moved those exact markers for people with similar profiles, with links to vetted vendors, delivered in 5 days. If it is useless I refund you. Up for a 20-minute call this week?
landing page
Know what to measure next, and what actually moved it $199 per quarter: an at-home panel, your ranked next test, and the products that shifted those markers for people like you - reserve with $49, credited to your first quarter Reserve your Austin or New York founding slot
deposit terms
Your $49 reserves one of 100 founding slots in Austin or New York and locks $199 per quarter for your first year, credited to your first panel. Your first kit ships the week of November 2, 2026. Fully refundable in one click any time before your kit ships.
Would you run this test?
One tap. The yes-share feeds the Demand pillar of this idea's score; nobody sees who answered.
Budgets are out-of-pocket estimates for a team of one to three, US market. Size the deposit to the deal, and check the terms before taking money in a regulated line.
Scorecard
One score that balances how trendy the idea is, the demand for it and its potential for 100x, with competition measured relative to every other idea in the catalog. Recent startup trends first, government priorities second.
67
Idea Score, 0-100 · raw 41.7 x 1.61
Active
competition: more crowded than 56% of ideas · headwind x0.72
+4.3
government priorities, secondary (66 matching grants)
Trend
58
Is the wave forming now? 2025-26 entrants vs 2023-24, rounds since 2025, the sector's live-batch direction, the 2026 trend analyst.
- Entrants 2025-26 vs 2023-24 (similar companies)13
- Rounds announced 2025+ in the sector69
- Sector direction (live batch)100
- 2026 trend analyst50
Demand
43
Does anyone want it? YC's current RFS, companies already paid for something similar, the operator judge, founders' yes-rate in decks, readers who would run the test.
- YC asks for it (current RFS: idea / sector)30
- Someone already pays (similar companies, recent / all-time)100
- Operator judge: real pain0
100x potential
56
Can it return a fund? The venture judge (double weight), market-size and moat axes, neighbours still alive, the technologist judge.
- Venture judge50
- Market size axis100
- Moat axis80
- Neighbours still alive32
- Technologist judge25
Score = 100 x cbrt(Trend x Demand x 100x) x (1 - 0.5 x crowding) + government bonus (max 5), calibrated so the 95th-percentile idea scores 90 (order never changes). A geometric mean: a weak pillar cannot be papered over. Percentiles are among the 272 ideas in the catalog; the terms matched were global, marketplace, measuring, biology, ranked, changes, consumer, sells.
The idea in full
- What
- Vitalane is a consumer app that sells at-home biology panels (blood, saliva, stool, wearable-derived) from independent labs and then sells the follow-on interventions - supplements, sleep and training protocols, coached programs - from vetted vendors in the same checkout. A multi-omic model trained on the returned panels ranks what each user should measure next and which vendor product moved that marker for people with similar profiles, so the app becomes the default front door for aging-related self-measurement rather than one more test kit. Vitalane runs its own courier and kit-fulfilment operation in five metros so turnaround is days, not weeks, and takes 15-30% of every panel and every product sold through it.
- Why now
- YC's Fall 2026 Requests for Startups names AI for the Aging Population for this cluster, and the S26 batch alone funded Illume Labs (24/7 Personal Health & Longevity Companion) and Gutgutgoose (personalized probiotics), while the radar shows zero crowded pitch phrases across recent companies - demand is being funded but no one owns the consumer transaction layer.
- Wedge: first customer and entry point
- Start with one cohort: people aged 45-60 already buying quarterly blood panels out of pocket. Sell a single subscription panel in two metros, hand-recruit ten supplement and coaching vendors, and take the cut on the second purchase.
- Path to 100x
- Consumer wellness, supplements and self-pay testing is a $100B+ global spend with no ranked, outcome-linked storefront; whoever holds the measurement history holds the recommendation slot for every subsequent purchase. Winner-takes-most comes from distribution: once the app is the default place a vendor reaches self-paying longevity buyers, vendors list here first, and the outcome data from prior panels makes the ranking hard for a second marketplace to copy.
- Ceiling
- Wellness claims stay unregulated only while the company avoids diagnosis, which caps how clinically useful the ranking can be and keeps average order value low.
- Closest real companies, as the generator saw them
- Illume Labs and Optimal sell a single owned companion product; Vitalane sells other people's panels and protocols and keeps the demand. Layers (dead, 2025) tried to own the full 30-minute measurement clinic and carried the capex; the marketplace version does not.
- Main risk
- Consumers churn after two panels because nothing they measure changes how they feel, and the repeat transaction never arrives.
Five judges
Each judge scores every idea in the catalog with a named rubric; the venture judge decides whether a card is shown at all (4-5 is venture-grade).
Venture investor
3/5
Owned courier and kit fulfilment in five metros is ops-heavy, and the stated churn after two panels kills the repeat take rate.
Bootstrapper
2/5
Own courier and kit fulfilment in five metros plus the stated two-panel churn makes repeat revenue the whole business and it is unproven.
Operator
1/5
Self-pay longevity panels are the definition of a vitamin, and the card itself fears churn after two panels because nothing changes.
Technologist
2/5
The multi-omic ranking model sits on other people's panels, and the claimed moat is a 15-30% supplement checkout, not technology.
Risk
1/5
At-home blood and stool panels plus intervention sales are labelled unregulated, ignoring CLIA, state lab rules and FTC health claims exposure.
trends
3/5
Direct Fall 2026 aging RFS fit with an uncrowded transaction layer, yet a wellness marketplace needed no 2025-2026 mechanism and churns on unchanged biomarkers.
Similar startups in the directory
Companies whose pitch matches most of the idea's terms (global, marketplace, measuring, biology, ranked, changes, consumer, sells): 62 all-time, 7 from the last two years. Same matching as Idea Check.
Real-time Nielsen ratings for Brands.Accelerate marketing and product…
Shibuya Blend Green Energy is a operator of a carbon trading platform.
Travel Ancillary Marketplace and Management Platform, Powered By AI.
Canovation is revolutionizing the CPG packaging industry with CanReseal®, an all-metal, fully resealable can that is compatible with existing manufacturing and supply chains, offering brands and consumers an all-in-one sustainable packaging solution.
The AI sales agent for CPG brands
Compliance that makes products ready for global markets.
Misprint is building Robinhood for Pokemon cards
AI native consumer lending platform for underserved Americans
Vanta for the consumer goods industry.
Atorie: Luxury Without the Price Tag
Cafler is the leading marketplace for car services online, and an AI- Operating System for mobility companies.
Realizse's mission is to accelerate the world's transition to sustainable products. Realizse is a Web3 platform for the circular economy. Realizse creates verifiable assets with digital twins supporting circularity, sustainability, and traceability for supply chain interoperability.
The generator's reference companies
Real companies the model named as closest when it wrote the card, with their fate. A check mark is a company the radar could verify in its directory.
Public money in this direction
US federal grants, SBIR/STTR awards and open opportunities from the radar's public-money feed, matched to the idea's terms; the sector totals give the context.
8
grants and programs matching the idea
1596
startup-relevant grants in Healthcare and bio
$854M
awarded in the sector, tracked
119
opportunities open now in the sector
NIH / NIAMS · SBIR phase I · $313K · posted 2025-08-01
- A cfDNA methylo-fragmentomic assay for prediction of risk-progression in Prostate Cancerawardhigh relevance
NIH / NCI · SBIR phase I · $386K · posted 2026-09-18
- A novel AI platform to detect cellular senescence and measure biological age using biofluidsawardhigh relevance
NIH / NIA · SBIR phase I · $397K · posted 2026-09-16
- I-Corps: Translation Potential of an Autonomous Brain-on-a-Chip Platform for Functional Drug Discoveryawardhigh relevance
National Science Foundation · I-Corps · $50K · posted 2026-08-14
- I-Corps: Translation Potential of an electroacoustic sensing technology using speakers as sensorsawardhigh relevance
National Science Foundation · I-Corps · $50K · posted 2026-08-10
National Science Foundation · I-Corps · $50K · posted 2026-08-10
- I-Corps: Translation Potential of Quantum Sensors for Diamond Tool Condition Monitoringawardhigh relevance
National Science Foundation · I-Corps · $50K · posted 2026-08-10
- Clinical Assay to Accurately Profile and Monitor the HIV-1 Reservoir in Chronic-treated Individuals to Guide Treatment Decisionsawardhigh relevance
NIH / NIAID · SBIR phase II · $300K · posted 2026-08-01
Market signal
What the radar sees in Healthcare and bio: new companies by cohort year, the forming YC batch, and outcomes since the February snapshot.
Healthcare and bio · 135 → 121 → 224 → 173 → 127 new companies 2022 → 2026 · 91% aliveYC F26 live: 2 in this cluster, 2% of the batch (was 6% in S26)Since February, of 442 YC companies here: 6 acquired, 6 shut down, 45 rewrote their pitch
Design attributes
The card is one cell of a designed set: every axis below was chosen before the text was written, and the text had to realize it.
- Buyer
- Consumer
- Business model
- Marketplace
- Path to 100x
- Creates a new category
- Market size
- $100B+ market
- Capital intensity
- Capital-medium (ops, field teams)
- Speed to revenue
- Revenue in 1-3 years
- Technical depth
- Deep tech: ML, hardware, bio
- Go-to-market
- Self-serve
- Moat
- Distribution moat
- Geography
- Global from day one
- Regulation
- Unregulated
- Vibe
- Hot space
Listed under
An idea sits in its own sector and in any sector its text clearly touches.
More ideas like this
Health and bio · Healthcare and bio
Bylaw Health
The licensed medical group behind your API call, in fifty states.
Bylaw Health holds the professional corporations, state clinician licenses, supervision agreements and payer enrollments in every US state, and exposes them as endpoints: create a clinician, attach a supervising physician, enroll a location with a payer, submit an encounter under a compliant entity.
Health and bio · Healthcare and bio
Bayworks
Licensed GMP manufacturing bays for personalized therapies, sold as bookable capacity.
Bayworks builds standardized, FDA-registered cleanroom modules inside hospital systems and partner CDMO sites, then runs a marketplace where drug sponsors book manufacturing slots by the batch instead of signing multi-year suite reservations.
Health and bio · Healthcare and bio
Assaygrid
Predicts which lab runs will fail before reagents are consumed, across every instrument vendor.
Assaygrid connects to the instrument fleet of pharma, biotech and industrial R&D organizations, learns from run telemetry, reagent lots, operator steps and outcomes, and flags runs likely to fail plus the parameter change that fixes them.
Health and bio · Healthcare and bio
Overturn
Agents that fight payer denials for health systems, then sell what wins.
Overturn deploys an agent workforce inside a health system's revenue cycle that reads each denial, pulls the governing payer medical policy, assembles the clinical record and files the appeal, working through existing EHR and clearinghouse integrations rather than new infrastructure.
Health and bio · Healthcare and bio
Labmesh
Agents that design, order and run preclinical experiments across a global lab network.
Labmesh gives a biotech or pharma scientist an agent that takes a hypothesis, decomposes it into assays, prices and routes each assay to a contract lab on its network, tracks samples, and returns structured results with the raw instrument files.
Health and bio · Healthcare and bio
ChartRail
The consented medical-records rail every AI clinic runs on.
An API that lets AI-native care companies pull a patient's complete medical record with verifiable consent, by operating as a qualified participant in the national health information exchange framework and as a registered clearinghouse.
Fictional company written 2026-08-22 from MarkosWeb data; the companies, grants and numbers around it are real and tracked. Treat the idea as a research prompt, not a plan.